Series A Investors & VC Firms in Switzerland

224 firms in this list, with a median first check of $540K. 59 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
ST Stepstone Group DFJMMTSD10 people · Leads rounds	88🔒	Charlotte	US	Seed–Late Stage	—	+ Add to CRM
AM AMR Action Fund HSMHJGBB14 people	88🔒	Boston	US	Seed–Series C	—	+ Add to CRM
KI Kinled Holding PA1 person · Leads rounds	88🔒	Hong Kong	HK	Seed–Series A	—	+ Add to CRM
SU Supermoon Capital PCGJMMCZ7 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Series A	$150K – $2.5M	+ Add to CRM
TI Tioga Capital Partners NPRJIL11 people	88🔒	London	GB	Pre-Seed–Series B	$540K – $5M	+ Add to CRM
AU Auriga Partners JCCLGRMC15 people	88🔒	Paris	FR	Seed–Growth	$540K – $5.4M	+ Add to CRM
SI Simon Capital FDJLNHNL5 people · Follows rounds	88🔒	Düsseldorf	DE	Seed–Series A	$540K – $10.8M	+ Add to CRM
RO Robin Capital RH1 person · Leads rounds	88🔒	Hamburg	DE	Pre-Seed–Growth	—	+ Add to CRM
IN Infinitas Capital RLRHSLAC17 people	88🔒	—		Pre-Seed–Late Stage	—	+ Add to CRM
FI Finch Capital Leads rounds	88🔒	Amsterdam	NL	Series A–Growth	$5.4M – $16.2M	+ Add to CRM
VE Venista Ventures CTMVFM3 people	88🔒	Cologne	DE	Pre-Seed–Series A	$55K – $165K	+ Add to CRM
CO Connect Ventures RSPBSTAN5 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series A	$500K – $5M	+ Add to CRM
ID Identity.vc JBTKMLRH9 people · Follows rounds	88🔒	Berlin	DE	Pre-Seed–Series A	$270K – $1.6M	+ Add to CRM
AE Aescap Life Sciences PKPDAMBJ14 people	88🔒	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
RT RTW Investments L.P. GMJMJKLC14 people	88🔒	New York	US	Seed–Series A	—	+ Add to CRM
NO Novalis Biotech JVWVBRCB7 people	88🔒	Ghent	BE	Pre-Seed–Series A	—	+ Add to CRM
SE Sectoral Asset Management FBGDCKOR9 people	88🔒	Montreal	CA	Series A–Late Stage	—	+ Add to CRM
RK RKKVC EKAK2 people · Leads rounds	88🔒	Nicosia	CY	Seed–Series A	$108K – $1.1M	+ Add to CRM
GR Green Generation Fund Follows rounds	88🔒	Berlin	DE	Pre-Seed–Series A	$540K – $2.7M	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLSV12 people	88🔒	Contern	LU	Seed–Late Stage	$10.8M	+ Add to CRM
NA naturalX Health Ventures MACPSBYC5 people · Leads rounds	88🔒	Karlsruhe	DE	Seed–Late Stage	$3.2M – $5.4M	+ Add to CRM
D1 D11Z	88🔒	Heilbronn	DE	Pre-Seed–Series A	—	+ Add to CRM
SI Sista TJMGNBAH6 people · Leads rounds	88🔒	Paris	FR	Seed–Series A	—	+ Add to CRM
OL Oltre Impact LALBNLRF8 people	88🔒	Milan	IT	Seed–Late Stage	$2.2M – $8.6M	+ Add to CRM

Stepstone Group

CharlotteSeed–Late Stage

DFJMMTSD10 people

AMR Action Fund

BostonSeed–Series C

HSMHJGBB14 people

Kinled Holding

Hong KongSeed–Series A

PA1 person

Supermoon Capital

San FranciscoPre-Seed–Series A$150K – $2.5M

PCGJMMCZ7 people

Tioga Capital Partners

LondonPre-Seed–Series B$540K – $5M

NPRJIL11 people

Auriga Partners

ParisSeed–Growth$540K – $5.4M

JCCLGRMC15 people

Simon Capital

DüsseldorfSeed–Series A$540K – $10.8M

FDJLNHNL5 people

Robin Capital

HamburgPre-Seed–Growth

RH1 person

Infinitas Capital

Pre-Seed–Late Stage

RLRHSLAC17 people

Finch Capital

AmsterdamSeries A–Growth$5.4M – $16.2M

Venista Ventures

ColognePre-Seed–Series A$55K – $165K

CTMVFM3 people

Connect Ventures

LondonPre-Seed–Series A$500K – $5M

RSPBSTAN5 people

Identity.vc

BerlinPre-Seed–Series A$270K – $1.6M

JBTKMLRH9 people

Aescap Life Sciences

AmsterdamSeed–Growth

PKPDAMBJ14 people

RTW Investments L.P.

New YorkSeed–Series A

GMJMJKLC14 people

Novalis Biotech

GhentPre-Seed–Series A

JVWVBRCB7 people

Sectoral Asset Management

MontrealSeries A–Late Stage

FBGDCKOR9 people

RKKVC

NicosiaSeed–Series A$108K – $1.1M

EKAK2 people

Green Generation Fund

BerlinPre-Seed–Series A$540K – $2.7M

Vesalius Biocapital III Partners SàRL

ConternSeed–Late Stage$10.8M

CSGGMLSV12 people

naturalX Health Ventures

KarlsruheSeed–Late Stage$3.2M – $5.4M

MACPSBYC5 people

D11Z

HeilbronnPre-Seed–Series A

Sista

ParisSeed–Series A

TJMGNBAH6 people

Oltre Impact

MilanSeed–Late Stage$2.2M – $8.6M

LALBNLRF8 people

Data sourced from public filings and firms' own websites — see our methodology.